Thermo Fisher Scientific | TMO - Ordinary Share Capital


Thermo Fisher Scientific reported $369.75M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Agilent USD 281.97M 252K Jun/2026
Becton, Dickinson and Co. USD 272.39M 98.21M Sep/2026
Bio Techne USD 157.05M 959K Sep/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Boston Scientific USD 1.48B 2.66M Dec/2025
Bruker USD 152.35M 130K Jun/2026
Charles River Laboratories USD 47.88M 148K Sep/2026
Danaher USD 703.4M 500K Sep/2026
Dentsply International USD 198.2M 1000K Sep/2026
Edwards Lifesciences USD 576.6M 400K Jun/2026
General Electric Aerospace USD 1.03B 4.21M Sep/2026
Henry Schein USD 110.54M 1.38M Sep/2026
Illumina USD 151.3M 607K Jun/2026
Intuitive Surgical USD 353.28M 885K Sep/2026
IQVIA Holdings USD 164.8M 200K Sep/2026
Laboratory Of America USD 81.2M 300K Sep/2026
Medtronic USD 1.28B 130K Jun/2026
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Olympus JPY 1.06B 38.28M Jun/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quest Diagnostics USD 110M 0 Sep/2026
Repligen USD 56.69M 266K Sep/2026
Revvity USD 111.59M 43K Sep/2026
Stryker USD 383.4M 416K Jun/2026
Thermo Fisher Scientific USD 369.75M 1.88M Sep/2026
Veracyte USD 80.39M 598K Sep/2026
Waters USD 98.19M 20K Jun/2026
Zimmer Biomet Holdings USD 190.1M 3.3M Sep/2026